News
The final battle of the Black Ops 6 Zombies map, Shattered Veil, is very unique as players will need to take down an undead dinosaur known as the Z-Rex. Players who want to make sure they don’t ...
Bioxodes has stopped enrolling people in a phase 2a stroke study after hitting the safety and efficacy endpoints, positioning the Belgian biotech to power into a potentially registrational trial.
ORLANDO, Fla., April 22, 2025 (GLOBE NEWSWIRE) -- Shapellx, a leading women's shapewear brand, announced today its launch of INNER ARMOR™ 2.0. The highly-anticipated, upgraded version of ...
Landeskog took another step closer to his Avalanche return before Game 2. For the first time since the 2022 Stanley Cup Playoffs, the Avs' captain participated in pregame warmups. His presence on ...
NEW ORLEANS (WVUE) - With the Mississippi River projected to rise above 15 feet at the Carrollton Gage on Tuesday, the U.S. Army Corps of Engineers, New Orleans District, has activated Phase II of ...
Two agents targeting angiopoietin-like protein 3 safely lowered lipid levels in phase 2 trials. Solbinsiran and SHR-1918 will be further studied in patients with high lipid levels in phase 3 trials.
Aleksander Barkov exited Game 2 against the Tampa Bay Lightning after ... dropping the Florida Panthers captain to a knee. Though Aleksander Barkov skated off on his own, he went straight to ...
Racing toward a $1.6 billion market, the biotech stopped work on RLYB212 in a rare maternal immune disorder in response to phase 2 data. RLYB212, an anti-HPA-1a antibody, was in phase 2 ...
Spinogenix announced open enrollment for its Phase II trial of SPG302, the first synaptic regenerative therapy for schizophrenia. According to the company, the launch of the Phase II trial comes amid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results